Skip to main content

Articles

Page 1 of 9

  1. Atezolizumab (ATZ) plus bevacizumab (BEV) combination therapy has recently been approved for the treatment of unresectable hepatocellular carcinoma. However, immune-related adverse events (irAEs), including pe...

    Authors: Ko Masaki, Motoyasu Miyzaki, Kota Mashima, Yasutaka Sumi, Kohei Noda, Syohei Ueno, Takashi Tanaka, Nobutaka Takahashi, Susumu Kaneshige and Hidetoshi Kamimura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:40
  2. Insufficient rehabilitation due to postfracture pain can result in muscle atrophy and joint contractures, which may affect the improvement of activities of daily living (ADL). This study investigated the impac...

    Authors: Eiji Kose, Hidetatsu Endo, Hiroko Hori, Shingo Hosono, Chiaki Kawamura, Yuta Kodama, Takashi Yamazaki, Toshimi Kimura and Hidetatstu Endo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:39
  3. This study aimed to assess the prevalence of dysphagia among nursing home residents and to examine the association between medication use and impaired swallowing function.

    Authors: Norio Watanabe, Minami Ebisujima, Takahiro Ichihara, Motozumi Ando and Masami Kawahara
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:38
  4. Dispensing errors associated with “same-name drugs” and “similar-name drugs” are common, negatively affecting patients. Using two pairs of error-induction models, this study analyzed pharmacists' gaze movement...

    Authors: Toshikazu Tsuji, Kenichiro Nagata, Masayuki Tanaka, Shiori Iwane, Shigeru Hasebe, Yuto Nishiyama, Nana Yoshikawa, Hiroyuki Watanabe, Shigeru Ishida, Takeshi Hirota, Ichiro Ieiri and Mayako Uchida
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:37
  5. 5-Hydroxytryptamine 3 receptor antagonists (5-HT3RAs) and dexamethasone are recommended to prevent azacitidine-induced nausea and vomiting. In clinical practice, 5-HT3RAs or metoclopramide is often used without d...

    Authors: Yoshinori Wakasugi, Yoshito Ikeda, Satoshi Noda, Makoto Murata and Shin-ya Morita
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:36
  6. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most common cause of hyponatremia. Although SIADH induced by carboplatin (CBDCA) plus nab-paclitaxel (nab-PTX) has been reported, there i...

    Authors: Hayahide Ooi, Yuki Asai, Yasumasa Sakakura and Masaaki Takahashi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:35
  7. Antimicrobial stewardship programs (ASPs) are essential for optimizing antimicrobial use, but many medium-sized hospitals lack infectious disease (ID) specialists. Ward pharmacists can contribute to ASPs, but ...

    Authors: Keisuke Sawada, Shuji Kono, Ryo Inose and Yuichi Muraki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:34
  8. While direct-acting antivirals (DAA) are effective treatment for hepatitis C virus (HCV) patients, concerns about drug-drug interactions (DDIs) remain a significant challenge. Although there are several studie...

    Authors: Daisuke Nakamoto, Yi Piao, Hajime Mizutani, Ryozo Wakabayashi, Satoshi Otokita, Alice Stead, Candido Hernandez and Masahisa Jinushi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:33
  9. Despite numerous studies on safety, acute kidney injury (AKI) caused by vancomycin and/or gentamicin remains a persistent medical issue. However, it remains unclear whether vancomycin AUC below 600 mg·h/L in c...

    Authors: Hirokazu Nakayama, Yoshitsugu Nakamura and Masayo Tanaka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:32
  10. Torasemide, a loop diuretic, is rarely used for pregnant women because of the risk of reduced placental blood flow resulting from decreased circulating plasma volume. We experienced a case of a newborn with me...

    Authors: Yumi Kitahiro, Mari Hashimoto, Yukako Sonda, Miki Yagi, Kotaro Itohara, Takumi Kido, Kazumichi Fujioka, Hitomi Imafuku, Tomohiro Omura and Ikuko Yano
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:31
  11. Bisphosphonates are the mainstay drugs for osteoporosis, but in clinical practice, they are often ineffective due to low compliance. However, there have been few studies examining compliance on a product-by-pr...

    Authors: Kenji Kabeya, Hiroki Satoh, Natsuyo Yanagi and Yasufumi Sawada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:30
  12. The aging of the population in many countries has made rehabilitation an essential part of improving the quality of life of older individuals. The risk factors for falls during rehabilitation include a history...

    Authors: Megumi Yahara-Hotta, Tomoyuki Ogino, Kisako Higa, Moka Yamakawa, Toshiyuki Shikata, Yoshihiro Kanata, Kenji Ikeda and Atsushi Kinoshita
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:29
  13. Statins, hydroxymethylglutaryl-CoA reductase inhibitors, possess neuroprotective properties. Given the potential neuroprotective properties of statins and their prevalent use in clinical settings, we aimed to ...

    Authors: Fuka Aizawa, Kenta Yagi, Maki Sato, Takahiro Niimura, Mitsuhiro Goda, Yuki Izawa-Ishizawa and Keisuke Ishizawa
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:27
  14. The number of individuals with chronic kidney disease (CKD) is increasing worldwide, including in Japan. Patients with advanced CKD are at an increased risk of serious adverse drug events associated with hospi...

    Authors: Akihiro Sonoda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:26
  15. Authors: Junichi Terashima, Takahiro Kambara, Eisei Hori, Masahiro Fukatsu, Yukina Ichiki, Eri Oki, Risako Koketsu, Rika Taguchi, Suzuka Mii, Ryoka Hiro, Teruhiro Sakaguchi, Hiroyuki Osanai, Tomoya Tachi and Tadashi Suzuki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:25

    The original article was published in Journal of Pharmaceutical Health Care and Sciences 2025 11:19

  16. Stenotrophomonas maltophilia (S. maltophilia) is a Gram-negative pathogen that causes opportunistic infections. Although the mortality rate among patients with nosocomial infections caused by S. maltophilia is hi...

    Authors: Michiya Tanuma, Takayuki Sakurai, Hidemasa Nakaminami and Masayo Tanaka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:24
  17. Arthrobacter woluwensis (A.woluwensis) is gram-positive rod that is endemic to natural environments such as soil, but reports of infections caused by this species are limited, and effective treatment methods have...

    Authors: Junichiro Date, Takayoshi Takeno, Shiro Watanabe and Akira Oda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:23
  18. Baloxavir marboxil (baloxavir) is a new anti-influenza drug that works as a cap-dependent endonuclease inhibitor. It is approved for prophylactic use against influenza in Japan, but there are few reports on th...

    Authors: Akihide Fujii, Tomohiro Oishi, Eisei Kondo, Zyunko Morihara, Yuka Ikeda, Hideyuki Sumida, Youko Ninomiya, Satoe Uesugi, Kimie Okazaki, Daisuke Yoshioka, Miyoko Kobayashi and Hideho Wada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:22
  19. Critically ill patients are susceptible to serious infections due to their compromised conditions and extensive use of medical devices, often requiring empiric broad-spectrum antimicrobial therapy. Failure of ...

    Authors: Ryota Tanaka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:21
  20. Azole antifungals are the standard treatment for pulmonary mycosis, which may develop during long-term immunotherapy for kidney transplant. Isavuconazole (ISCZ) is a cytochrome P450 (CYP) 3 A inhibitor that ha...

    Authors: Hayato Yokota, Yumiko Akamine, Harumi Hatakeyama, Hideaki Kagaya, Sho Sakamoto, Mitsuru Saito, Masahide Takeda, Kazuhiro Sato, Katsutoshi Nakayama and Masafumi Kikuchi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:20
  21. Heart failure has a high readmission rate, but interventions by multiple professionals are effective. Although there is growing interest in the management of heart failure by community pharmacists in Japan, no...

    Authors: Junichi Terashima, Takahiro Kambara, Eisei Hori, Masahiro Fukatsu, Yukina Ichiki, Eri Oki, Risako Koketsu, Rika Taguchi, Suzuka Mii, Ryoka Hiro, Teruhiro Sakaguchi, Hiroyuki Osanai, Tomoya Tachi and Tadashi Suzuki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:19

    The Correction to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2025 11:25

  22. Population pharmacokinetic (PPK) models of vancomycin (VCM) commonly use creatinine clearance (CLcr) as a covariate for clearance (CL). However, relying on CLcr in patients of advanced age may lead to inaccura...

    Authors: Keisuke Takada, Masaru Samura, Yuki Igarashi, Ayako Suzuki, Tomoyuki Ishigo, Satoshi Fujii, Yuta Ibe, Hiroaki Yoshida, Hiroaki Tanaka, Fumiya Ebihara, Takumi Maruyama, Yukihiro Hamada, Toshiaki Komatsu, Atsushi Tomizawa, Akitoshi Takuma, Hiroaki Chiba…
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:18
  23. Imbalance between gastrointestinal peptides has been implicated as a cause of chemotherapy-induced nausea and vomiting (CINV) and anorexia in cancer patients. This study comprehensively evaluated the changes i...

    Authors: Ryosuke Tatsuta, Ryota Tanaka, Asami Tashibu, Yosuke Suzuki, Kosuke Suzuki, Tomotaka Shibata, Tadasuke Ando, Toshitaka Shin, Yuhki Sato and Hiroki Itoh
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:17
  24. Comprehensive medication regimens increase the risk of potential drug-drug interactions, adversely affecting health outcomes regardless of age. This risk is particularly pertinent in the context of medical voc...

    Authors: Jennifer-Daniele Schmitz, Roman Korte, Andreas Lison, Joachim Gerß and Christoph Schulze
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:16
  25. Horse antithymocyte globulin (hATG) is an important therapeutic option for aplastic anemia (AA). However, hATG carries the risk of fatal anaphylaxis, and skin tests are performed to identify high-risk patients...

    Authors: Satoshi Yuyama, Mitsuaki Oura, Tatsuya Isezaki, Daisuke Ikeda, Kanayuki Kitahara, Ryohkan Funakoshi and Kosei Matsue
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:15
  26. Vancomycin (VCM) induces nephrotoxicity in a dose-dependent manner, and patients with risk factors for nephrotoxicity have been reported to develop nephrotoxicity even within the effective concentration range....

    Authors: Yoshihiko Matsuki, Yutaro Kozima, Megumi Yanagi, Ken-ichi Sako, Tamaki Watanabe, Nobuhiro Yasuno and Shigekazu Watanabe
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:14
  27. It has been reported that the protein binding rate of vancomycin (VCM) varies among individual patients. So, the authors investigated relevant factors that may affect free VCM concentration and target attainme...

    Authors: Toshiharu Urakami, Yusuke Oka, Takashi Matono and Yosuke Aoki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:13
  28. Considering the global threat of antimicrobial resistance (AMR), Japan implemented a national action plan in 2016 that emphasized antibiotic education for healthcare professionals. However, pharmacy education ...

    Authors: Masayuki Maeda and Kozue Yamaguchi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:12
  29. In Japan, anticholinergic drugs were contraindicated for glaucoma, regardless of subtype. The contraindication in patients with open-angle glaucoma (OAG) led to excessive medication restrictions because antich...

    Authors: Yukinori Yamada, Tetsuya Murase, Emiko Mashida, Yuki Kakeda, Yuuka Shibata and Hiroaki Matsuo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:11
  30. Stroke is a leading cause of death, reducing disability-free life expectancy. After acute treatment, patients require rehabilitation to prevent recurrence. Continued use of medication is crucial for recurrence...

    Authors: Yuko Fukuda, Risa Ito, Misaki Kakihana, Tsutomu Takahashi, Tetsuji Kanemoto, Toshiyuki Sahara, Masahiko Tsujikawa and Mitsuko Onda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:10
  31. The Anticholinergic Risk Scale and Total Anticholinergic Load were developed to assess the risks associated with anticholinergic drugs. Recently, the Japan Anticholinergic Risk Scale was introduced; however, t...

    Authors: Yusuke Kan, Maki Doi and Yoshihiro Uesawa
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:8
  32. Cataract surgeries are increasing annually, making appropriate medical management essential. The routine use of systemic antimicrobial agents for preventing surgical site infections lacks strong evidence and m...

    Authors: Kazutaka Uchida, Keita Takahama, Kenshiro Higashi, Yuki Kusano, Koki Matsumoto, Yoshihiro Nakagawa and Kazutaka Oda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:9
  33. Pharmaceutical formularies play a crucial role in guiding medication use by balancing clinical effectiveness and cost efficiency. Although formulary implementation has been increasing in Japan, comprehensive e...

    Authors: Nakaba Okamura, Ayano Katagiri, Tomoya Komori, Kei Kawanabe, Hirofumi Koike, Yukiko Sahashi and Rie Kubota
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:7
  34. Toxic epidermal necrolysis (TEN), a severe cutaneous hypersensitivity reaction induced particularly by drugs, is diagnosed when there is a fever of ≥ 38 °C, mucocutaneous symptoms, a rash with multiple erythem...

    Authors: Yoshihiro Nishita, Masatoshi Taga, Nozomi Arakawa, Tomoki Ishida, Sawako Ochiai, Hiroto Ono, Fumiaki Taga and Togen Masauji
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:6
  35. Remdesivir is recommended to treat hospitalized patients with coronavirus disease 2019 (COVID-19). Remdesivir is known to affect glucose metabolism in individuals with and without diabetes. However, little is ...

    Authors: Yasunori Nagano, Hisae Aoki, Juri David, Naoko Iwahashi Kondo, Makimi Aizawa, Toshiyuki Sumita, Yuki Hamada, Yuki Yamamoto and Kaoru Yamada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:5
  36. Community pharmacists play a crucial role in promoting medication safety within the community healthcare team. Effective communication by community pharmacists with other health professionals is essential to f...

    Authors: Mitsuaki Ishii, Sachiko Ozone, Shoichi Masumoto and Tetsuhiro Maeno
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:4
  37. Ensitrelvir is a novel SARS-CoV-2 3-chymotrypsin-like protease inhibitor, similar to nirmatrelvir/ritonavir. Several case reports have demonstrated the efficacy of 3-chymotrypsin-like protease inhibitors in tr...

    Authors: Yuki Miyata, Ryo Yamaguchi, Takehito Yamamoto, Toshiyuki Kishida, Kazuhiko Ikeuchi, Hiroaki Harada, Takeya Tsutsumi, Keishi Fujio and Tappei Takada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:3
  38. Antithrombotic medications are essential for the management of abnormal clot formation. However, their availability, pricing, and affordability in Ethiopia, particularly in Addis Ababa, have not been comprehen...

    Authors: Selam Birhanu, Melaku Tileku Tamiru, Hanan Muzeyin Kedir and Tamrat Assefa Tadesse
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:2
  39. Authors: Akihiko Futamura, Takenao Koseki, Junichi Iida, Akito Suzuki, Nobuyuki Muroi, Michiaki Myotoku, Hiroki Maki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi, Keiichiro Higashi and Masanobu Usui
    Citation: Journal of Pharmaceutical Health Care and Sciences 2025 11:1

    The original article was published in Journal of Pharmaceutical Health Care and Sciences 2024 10:67

  40. Continuous subcutaneous administration of injectable opioids is simple and effective; however, skin disorders may occur when high opioid dosages are used. Therefore, we investigated opioid injection drugs with...

    Authors: Rei Tanaka, Takahiro Hashizume, Tadashi Hisanaga, Shinya Masuda, Junya Sato, Hiroshi Ishikawa, Hironori Tanaka, Akiyoshi Saitoh, Tetsumi Sato, Takeshi Kamoshida, Tetsu Sato and Michihiro Shino
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:82
  41. Adverse events (AEs) induced by cancer chemotherapy reduce not only patient quality of life (QOL) but also the efficacy of treatment. Management of AEs can therefore improve both the efficacy and safety of can...

    Authors: Hironori Fujii
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:81
  42. In the dose titration of transdermal fentanyl to prevent unrelieved pain, it is important to consider not only dose adjustment, but also the titration period, which is influenced by the time required to reach ...

    Authors: Satoshi Mizuno, Makiko Takabayashi, Hiroko Makihara, Kazuhiro Ogai, Kei Tsukui, Yuriko Ito, Takahiro Kawakami, Yusuke Hara, Arimi Fujita, Yoshihiro Tokudome, Tomoko Akase, Yukio Kato, Tsutomu Shimada and Yoshimichi Sai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:80
  43. Oncolytic virus therapy is a rapidly evolving emerging approach for the medical management of cancer. Talimogene laherparepvec (T-VEC) is the first and only Food and Drug Administration (FDA)-approved oncolyti...

    Authors: Yifan Hong, Kebin Cheng, Han Qu, Yuting Wang, Yuanyuan Wang, Guorong Fan and Zhenghua Wu
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:79
  44. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, offering hope for various malignancies by enhancing the immune response against tumors. However, ICIs are associated with unique immune...

    Authors: Tatsuki Ikeda, Satoru Nihei, Kazuki Saito, Junichi Asaka and Kenzo Kudo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:78
  45. Aminoglycosides are crucial for treating multidrug-resistant gram-negative infections and endocarditis. However, aminoglycosides are associated with significant risks of nephrotoxicity, necessitating careful d...

    Authors: Yasutaka Shinoda, Kengo Ohashi, Tomoko Matsuoka, Kaori Arai, Nao Hotta and Eiseki Usami
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:77
  46. Dual‐antiplatelet therapy (DAPT) and proton pump inhibitor (PPI) are frequently prescribed after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) placement. However, studies that evaluat...

    Authors: Yutaro Ide, Go Morikawa, Kyohei Yoshida, Yuki Takano, Ken Kubota, Katsuko Okazawa and Takeo Yasu
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:76
  47. Pain and inflammation are the major medical condition commonly addressed with traditional remedies. Acacia seyal is a traditional herb widely used in Ethiopian folk medicine for pain management. However, its effe...

    Authors: Gena Kedir, Akeberegn Gorems Ayele and Workineh Shibeshi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:75
  48. Post-stroke delirium affects between 24% and 43% of patients, and negatively impacts patient outcomes. Recently, research attention has been on preventive interventions for delirium, with melatonin receptor ag...

    Authors: Yukiko Miyoshi, Yuki Shigetsura, Daiki Hira, Takakuni Maki, Hirotsugu Kawashima, Naoko Sugita, Noriko Sugawara, Noriaki Kitada, Machiko Hirai, Masayoshi Kawata, Hiroki Endo, Yusuke Kojima, Keiko Ikuta, Yurie Katsube, Natsuki Imayoshi, Shunsaku Nakagawa…
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:74
  49. A simple suspension method, where solid formulations are disintegrated and suspended by being soaked in warm water followed by tube administration, is widely used, especially for elderly patients with dysphagi...

    Authors: Ginjiro Kato, Hidemichi Mitome, Syu Takeda, Noriaki Hidaka, Mamoru Tanaka and Kazuki Akira
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:73

Official journal of JSPHCS

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.2
    5-year Journal Impact Factor: 1.4
    Source Normalized Impact per Paper (SNIP): 0.557
    SCImago Journal Rank (SJR): 0.312

    Speed 2024
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 79

    Usage 2024
    Downloads: 301,150
    Altmetric mentions: 116